NCT03354455View on ClinicalTrials.gov

Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

September 16, 2018

Study Completion Date

September 16, 2018

Conditions

Dyskinesia, Drug-InducedParkinson Disease

Interventions

DEVICE

Repetitive transcranial magnetic stimulation

"Frequency: 1 Hz., Pulse shape: biphasic, Duration: 30 minutes (1800 pulses).~Neuronavigation: MRI-guided and robot-assisted neuronavigation using Localite software and an Axilum robot."

Trial Locations (1)

2650

Danish Research Centre for Magnetic Resonance, Hvidovre

All Listed Sponsors

collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

collaborator

Danish Movement Disorder Society (DANMODIS)

UNKNOWN

collaborator

Danish Parkinson Association

OTHER

lead

Danish Research Centre for Magnetic Resonance

OTHER

NCT03354455 - Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease | Biotech Hunter | Biotech Hunter